Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 11, Issue 12 (2022)

Performance of different strawberry (Fragaria x ananassa Duch.) cultivars for yield, yield attributing parameters and benefit: Cost ratio under farmer’s field condition (Baadi) in the plain region of Chhattisgarh

Author(s):
Gowardhan Kumar Verma, SP Sharma, HK Panigrahi and Sangeeta
Abstract:
Strawberry (Fragaria x ananassa Duch.) is one of the most important soft fruit belongs to the family Rosaceae. It is mainly a temperate region fruit crop but also can be grown in tropical and sub-tropical climatic region due to availability of day neutral and thermo-insensitive varieties. A research trial was conducted in three farmer’s field condition (Baadi) at village-Bharregaon, (dist.-Rajnandgaon, Chhattisgarh) and the research farm of College of Horticulture and Research Station, Rajnandgaon (C.G.) during the winter spring season of the year 2017-18 to evaluate different strawberry cultivars for yield, yield attributing parameters and benefit: cost ratio under farmer’s field condition (Baadi) in the plain region of Chhattisgarh. The experiment was conducted with two best performing strawberry cultivars namely Nabila and Camarosa replicated four times using student’s t-test. Result revealed that regarding yield and yield attributing parameters, cv. Nabila recorded maximum number of fruits per plant (37.32), fruit weight (23.90 g/fruit), fruit length (5.35 cm), fruit diameter (3.25 cm), fruit yield (745.33 g/plant), fruit yield (361.40 q/ha) and maximum benefit: cost ratio (4.06), while the minimum was recorded in cv. Camarosa.
Pages: 2219-2221  |  261 Views  173 Downloads


The Pharma Innovation Journal
How to cite this article:
Gowardhan Kumar Verma, SP Sharma, HK Panigrahi, Sangeeta. Performance of different strawberry (Fragaria x ananassa Duch.) cultivars for yield, yield attributing parameters and benefit: Cost ratio under farmer’s field condition (Baadi) in the plain region of Chhattisgarh. Pharma Innovation 2022;11(12):2219-2221.

Call for book chapter